EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meeting report on FASEB protein arginine methylation: mechanism to therapeutics

David Shechter, Rong Huang, Pooja Shah, Thierry Dubois, Xiao-Meng Li, Andrey Parhitko, Mark T Bedford, Shihuan Kuang, Taiping Chen, Yanzhong Yang, Purusharth Rajyaguru, Dalia Barsyte-Lovejoy und 11 weitere

Journal of Biological Chemistry · 2026

DOI: 10.1016/j.jbc.2026.111448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026. Verfasst von David Shechter und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: david.shechter@einsteinmed.edu. Hauptthemen laut MEDLINE: Arginine, Protein-Arginine N-Methyltransferases. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Uehara Memorial Foundation, The Japanese Biochemical Society, University of Tsukuba.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The inaugural FASEB conference Protein Arginine Methylation: Mechanism to Therapeutics was held in Tsukuba, Japan (January 5-8, 2026), and brought together investigators studying protein arginine methyltransferases (PRMTs) and its methylarginine product. Post-translational arginine methylation, found as monomethylarginine (MMA/Rme1), asymmetric dimethylarginine (ADMA/Rme2a), and symmetric dimethylarginine (SDMA/Rme2s), is increasingly recognized as a central regulator of RNA metabolism, chromatin function, and cellular stress responses. Presentations highlighted emerging directions for the field, including mechanisms linking PRMT activity to RNA processing and gene expression, roles in genome stability, identification of new methylarginine reader proteins, and connections between PRMT function and cellular metabolism. Work on immune and antiviral pathways and neuroscience further expanded the biological scope of PRMT activity. At the same time, significant advances in chemical probes, degraders, and selective inhibitors are enabling more precise interrogation of PRMT biology and accelerating efforts to translate these discoveries into therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineProtein-Arginine N-MethyltransferasesHumansMethylationAnimalsProtein Processing, Post-Translational

Stichwörter der Autor:innen

PRMTsRNA processingcancer therapeuticschemical probesgenome stabilitymethylargininemethylarginine reader proteinsprotein arginine methylation

Substanzen

ArginineProtein-Arginine N-Methyltransferases

Autor:innen und Institutionen

  • Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: david.shechter@einsteinmed.edu.
  • Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana, USA.
  • Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Institut Curie, PSL University, Sorbonne University, Translational Research Department & CNRS UMR144, Paris, France.
  • The Hong Kong University of Science and Technology (Guangzhou), Guangzhou, China.
  • Aging Institute, UPMC and University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • The Uehara Memorial Foundation
  • The Japanese Biochemical Society
  • University of Tsukuba

Zitieren

APA

Shechter, D., Huang, R., Shah, P., Dubois, T., Li, X. M., Parhitko, A., Bedford, M. T., Kuang, S., Chen, T., Yang, Y., Rajyaguru, P., Barsyte-Lovejoy, D., Zhao, X., Xu, W., Davies, C. C., Tikhanovich, I., Tran, N. T., Kako, K., Hashimoto, M., …, & Yu, M. C. (2026). Meeting report on FASEB protein arginine methylation: mechanism to therapeutics. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2026.111448

Vancouver

Shechter D, Huang R, Shah P, Dubois T, Li XM, Parhitko A, et al. Meeting report on FASEB protein arginine methylation: mechanism to therapeutics. Journal of Biological Chemistry. 2026. doi:10.1016/j.jbc.2026.111448

BibTeX
@article{Shechter2026,
  author = {Shechter, David and Huang, Rong and Shah, Pooja and Dubois, Thierry and Li, Xiao-Meng and Parhitko, Andrey and Bedford, Mark T and Kuang, Shihuan and Chen, Taiping and Yang, Yanzhong and Rajyaguru, Purusharth and Barsyte-Lovejoy, Dalia and Zhao, Xinyang and Xu, Wei and Davies, Clare C and Tikhanovich, Irina and Tran, Ngoc Tung and Kako, Koichiro and Hashimoto, Misuzu and Luo, Minkui and Hevel, Joan M and Fukamizu, Akiyoshi and Yu, Michael C},
  title = {Meeting report on FASEB protein arginine methylation: mechanism to therapeutics},
  journal = {Journal of Biological Chemistry},
  year = {2026},
  doi = {10.1016/j.jbc.2026.111448}
}
Kostenlos starten →